These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 6938964

  • 1. Covalent binding and hemolytic activity of complement proteins.
    Law SK, Lichtenberg NA, Levine RP.
    Proc Natl Acad Sci U S A; 1980 Dec; 77(12):7194-8. PubMed ID: 6938964
    [Abstract] [Full Text] [Related]

  • 2. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
    Pangburn MK, Müller-Eberhard HJ.
    J Exp Med; 1980 Oct 01; 152(4):1102-14. PubMed ID: 6903192
    [Abstract] [Full Text] [Related]

  • 3. Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
    Pangburn MK, Schreiber RD, Müller-Eberhard HJ.
    J Exp Med; 1981 Sep 01; 154(3):856-67. PubMed ID: 6912277
    [Abstract] [Full Text] [Related]

  • 4. Inhibition of complement components C3 and C4 by cadralazine and its active metabolite.
    Andersson M, Hanson A, Englund G, Dahlbäck B.
    Eur J Clin Pharmacol; 1991 Sep 01; 40(3):261-5. PubMed ID: 2060562
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Covalent modification of fourth component of human complement with primary amines. Binding studies with metastable fragment C4b and with C4.
    Gorski JP, Silversmith R, Fiebeger S, Moilanen T.
    J Biol Chem; 1982 Sep 25; 257(18):10948-54. PubMed ID: 6980883
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Complement inhibition at the level of C3 or C5: mechanistic reasons for ongoing terminal pathway activity.
    Mannes M, Dopler A, Zolk O, Lang SJ, Halbgebauer R, Höchsmann B, Skerra A, Braun CK, Huber-Lang M, Schrezenmeier H, Schmidt CQ.
    Blood; 2021 Jan 28; 137(4):443-455. PubMed ID: 33507296
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The biochemistry of opsonization: central role of the reactive thiolester of the third component of complement.
    Hostetter MK, Krueger RA, Schmeling DJ.
    J Infect Dis; 1984 Nov 28; 150(5):653-61. PubMed ID: 6491376
    [Abstract] [Full Text] [Related]

  • 14. The internal thioester and the covalent binding properties of the complement proteins C3 and C4.
    Law SK, Dodds AW.
    Protein Sci; 1997 Feb 28; 6(2):263-74. PubMed ID: 9041627
    [Abstract] [Full Text] [Related]

  • 15. Evidence for presence of an internal thiolester bond in third component of human complement.
    Tack BF, Harrison RA, Janatova J, Thomas ML, Prahl JW.
    Proc Natl Acad Sci U S A; 1980 Oct 28; 77(10):5764-8. PubMed ID: 6934510
    [Abstract] [Full Text] [Related]

  • 16. The covalent binding story of the complement proteins C3 and C4 (I) 1972-1981.
    Law SKA, Levine RP.
    Immunobiology; 2019 Nov 28; 224(6):827-833. PubMed ID: 31445811
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties.
    Isenman DE, Kells DI, Cooper NR, Müller-Eberhard HJ, Pangburn MK.
    Biochemistry; 1981 Jul 21; 20(15):4458-67. PubMed ID: 7284336
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.